Healthcare
Eli Lilly and Company LLY
$1431.67
-11.84 (-0.82%) today
LLY
Eli Lilly and Company—
Today
— · USD
Loading prices…
Revenue by Product & Services
Loading…
Revenue Breakdown
—
Past 5 years
Loading prices…
Profit & Cash Flow
Show
RevenueOperating IncomeFree Cash FlowExpenses
Each bar stacks the items you turn on; hover a bar for each amount. Expenses = revenue minus operating income. Figures from SEC filings.
Tip: click any year on a chart to see all of its numbers.
Market Cap
$1.29T+25325%
Revenue
$65.2B+226%
Break down by
Loading revenue breakdown…
Operating Income
—
Not reported for this period
Net Income
$20.6B+10218%
Free Cash Flow
$16.8B+199%
Revenue to Market Cap
0.07x-98%
P/E Ratio
45.80x+1732%
Operating Margin
—
Not reported for this period
Debt to Equity
1.54x+79%
Shares Outstanding
899M+1262%
Dividend Yield
0.6%-79%
Latest LLY news
- Eli Lilly is trouncing Nvidia — and the weight-loss drug trade is beating AI again11/16/2026
- SLS Stock Jumps After-Hours: Retail Eyes Lilly’s Cancer Deal for Valuation Clues — 2 Big Investors Grab Shares11/17/2026
- Stocks Carry Weekly Gains Into a Wall of Chart Resistance as Volatility Cools11/17/2026
- Stipple Bio Announces Multi-Target Multi-Modality Oncology Research Collaboration with Lilly11/16/2026
- Sector Update: Healthcare Stocks Decline Late Afternoon11/16/2026
- Eli Lilly to Acquire Calytrix Bio in Up to $1.5 Billion Deal11/16/2026
Prices and news from Yahoo Finance (may be delayed). Company results from SEC filings (available from 2007). Not investment advice.